# Testing BRCA 1/2 Mutation Using Next Generation Sequencing

> **NCT02151747** · — · COMPLETED · sponsor: **Severance Hospital** · enrollment: 12 (actual)

## Conditions studied

- Breast Neoplasms
- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02151747
- **Lead sponsor:** Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02151747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02151747, "Testing BRCA 1/2 Mutation Using Next Generation Sequencing". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02151747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*